Clear Cell Renal Cell Carcinoma

SAN DIEGO – July 27, 2026 Kura Oncology, Inc. has reported updated Phase 1a clinical data from the ongoing...

MELBOURNE, Australia, and INDIANAPOLIS, Ind., July 21, 2026 Telix Pharmaceuticals announced that the first patient has been dosed in...

PASADENA, Calif., July 17, 2026 Xencor, Inc. announced that Phase 1 clinical results for XmAb819, its investigational ENPP3 ×...

SAN DIEGO, July 14, 2026 Kura Oncology announced that updated long-term follow-up data from the ongoing FIT-001 Phase 1a...

HAYWARD, Calif., July 1, 2026 Arcus Biosciences, Inc. announced the publication of new translational research in Nature demonstrating a...